Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday

Published 24/01/2023, 13:14
Updated 24/01/2023, 14:40
© Reuters.  Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday

© Reuters. Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday

Benzinga -

  • Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading.
  • Baird boosted the price target for Danaher Corporation (NYSE: DHR) from $315 to $321. Baird analyst Catherine Schulte maintained an Outperform rating. Danaher shares gained 0.3% to $277.80 in pre-market trading.
  • Piper Sandler increased the price target for Inter Parfums, Inc. (NASDAQ: IPAR) from $118 to $130. Piper Sandler analyst Korinne Wolfmeyer maintained an Overweight rating on the stock. Inter Parfums shares rose 0.7% to close at $113.79 on Monday.
  • Wells Fargo cut the price target for Omnicell, Inc. (NASDAQ: OMCL) from $71 to $65. Wells Fargo analyst Stan Berenshteyn maintained an Overweight rating. Omnicell shares gained 3.2% to close at $57.81 on Monday.
  • Barclays raised Thermo Fisher Scientific Inc. (NYSE: TMO) price target from $570 to $630. Barclays analyst Luke Sergott maintained an Overweight rating on the stock. Thermo Fisher Scientific shares fell 0.8% to $600.00 in pre-market trading.
  • Bernstein cut Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $95 to $80. Bernstein analyst Stacy Rasgon downgraded the stock from Outperform to Market Perform. AMD shares fell 2.2% to $74.82 in pre-market trading.
  • Telsey Advisory Group cut Amazon.com, Inc. (NASDAQ: AMZN) price target from $140 to $125. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating on the stock. Amazon shares fell 0.4% to $97.17 in pre-market trading.
  • JP Morgan cut Allogene Therapeutics, Inc. (NASDAQ: ALLO) price target from $20 to $11. JP Morgan analyst Brian Cheng upgraded the stock from Neutral to Overweight. Allogene Therapeutics shares gained 7.4% to $7.37 in pre-market trading.
  • Stifel boosted Xylem Inc. (NYSE: XYL) price target from $115 to $124. Stifel analyst Nathan Jones upgraded the stock from Hold to Buy. Xylem shares rose 1.1% to $102.51 in pre-market trading.
  • Jefferies raised Sumo Logic, Inc. (NASDAQ: SUMO) price target from $8.5 to $11. Jefferies analyst Brent Thill maintained a Hold rating on the stock. Sumo Logic shares rose 2.8% to $10.15 in pre-market trading.
  • UBS lowered Sealed Air Corporation (NYSE: SEE) price target from $65 to $59. UBS analyst Joshua Spector downgraded the stock from Buy to Neutral. Sealed Air shares fell 1.5% to $52.99 in pre-market trading.
Check This Out: Context Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.